New no-releasing steroids for the treatment of retina and...

C - Chemistry – Metallurgy – 07 – J

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07J 7/00 (2006.01) A61K 31/573 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2731520

The invention relates to compounds of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof (formula I) The compounds are useful for treating diabetic macular edema, diabetic retinopathy, macular degeneration, age- related macular degeneration and other diseases of retina and macula lutea.

L'invention porte sur des composés de formule générale (I) et sur des sels pharmaceutiquement acceptables ou des stéréo-isomères de ceux-ci (formule 1). Les composés sont utiles pour traiter un dème maculaire diabétique, une rétinopathie diabétique, une dégénérescence maculaire, une dégénérescence maculaire liée à l'âge et d'autres maladies de la rétine et de la macula lutea.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

New no-releasing steroids for the treatment of retina and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New no-releasing steroids for the treatment of retina and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New no-releasing steroids for the treatment of retina and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1389318

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.